Qube Research & Technologies (QRT)
PVLA

Qube Research & Technologies (QRT)’s Palvella Therapeutics PVLA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-311
Closed -$94K – 3117
2021
Q4 		$94K Buy
+311
New +$99.6K ﹤0.01% 2150

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PVLA Position: Q1 2022 in Review

Qube Research & Technologies (QRT) sold out of Palvella Therapeutics (PVLA) in Q1 2022, closing a stake of 311 shares — an estimated $94K sold.

Qube Research & Technologies (QRT) first reported a position in PVLA in Q4 2021 and held it in 1 quarter. The position peaked at $94K in Q4 2021. 71 funds tracked by Wall St. Rank hold PVLA as of Q1 2022.

  • Qube Research & Technologies (QRT) reported no remaining Palvella Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 311 Palvella Therapeutics shares in Q1 2022, an estimated $94K.
  • Qube Research & Technologies (QRT) first reported a position in Palvella Therapeutics in Q4 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Palvella Therapeutics position peaked at $94K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2022, filed 9 May 2022.